|
|
Article: BloodStor™ Stem Cell Biopreservation Media Platform Launched by BioLife Solutions.
- Article from:
- Blood Weekly
- Article date:
- September 17, 2009
CopyrightCOPYRIGHT 2009 NewsRX. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan. All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)
|
BioLife Solutions, Inc. (BULLETIN BOARD: BLFS) , a leading developer, manufacturer, and marketer of biopreservation tools for cells, tissues, and organs, announced the launch of its BloodStor biopreservation media product platform. The product family includes BloodStor 55-5 for cryopreservation of umbilical cord blood stem cells, as well as other variants for peripheral blood derived stem cells. BloodStor 55-5, packaged in standard, single-use sterile vials of various fill volumes, is formulated with 55% USP grade DMSO and 5% USP grade dextran-40 in water for injection quality (WFI) water and supports a common cord blood processing protocol (see also Cord Blood).
...
Related newspaper, magazine, and journal articles:
|
|
Article: BioLife Solutions Announces Record Revenue and ...
PR Newswire;
January 26, 2009 ;
700+ words
... ... objectives for 2009." BioLife Solutions will be presenting and ... index.html). About BioLife Solutions, Inc.: BioLife Solutions develops and markets patented ... tissue engineering, cord blood banking, drug discovery ...
|
|